RIG-I is a cytosolic helicase that senses 5′-ppp RNA contained in negative-strand RNA viruses and triggers innate antiviral immune responses. Calorimetric binding studies established that the RIG-I C-terminal regulatory domain (CTD) binds to bluntend double-stranded 5′-ppp RNA a factor of 17 more tightly than to its single-stranded counterpart. Here we report on the crystal structure of RIG-I CTD bound to both blunt ends of a self-complementary 5′-ppp dsRNA 12-mer, with interactions involving 5′-pp clearly visible in the complex. The structure, supported by mutation studies, defines how a lysine-rich basic cleft within the RIG-I CTD sequesters the observable 5′-pp of the bound RNA, with a stacked phenylalanine capping the terminal base pair. Key intermolecular interactions observed in the crystalline state are retained in the complex of 5′-ppp dsRNA 24-mer and full-length RIG-I under in vivo conditions, as evaluated from the impact of binding pocket RIG-I mutations and 2′-OCH 3 RNA modifications on the interferon response.
Host defense against infection by invading viral and bacterial pathogens is critically dependent on the initiation and maintenance of the finely tuned primary innate immune response [1] [2] [3] [4] , a rapid protective response that is coupled to subsequent adaptive immunity, thereby providing long-term protection based on immunological memory. The innate immune system is equipped with a number of pattern-recognition receptors that detect characteristic microbial components, including foreign nucleic acids and their characteristic structures, ranging from long double-stranded RNA (dsRNA) and 5′-triphosphorylated (ppp) RNA, to unmethylated CpG DNA 5 . Such nucleic acid molecules are either less frequent (or absent) in the host organism or they are localized in other cellular compartments than self nucleic acids. In contrast to acquired antibody-mediated immunity, nucleic acids of viral origin are detected by host-cell constitutively expressed pathogen-associated molecular pattern (PAMP) recognition receptors (PRRs). These receptors are localized either to endosomal compartments commonly occupied by pathogens or to the cytosol, resulting in the stimulation of innate antiviral immune responses, including the induction of interferon regulatory factors (IRFs) and NF-κB, that in turn regulate the production of type I interferons (IFNs) and proinflammatory cytokines and chemokines, respectively, as well as increased expression of co-stimulatory molecules essential for the activation of T cells. Immunorecognition of viral nucleic acids leads to the suppression of viral replication in the infected cell, and cytokine expression attracts and activates innate effector cells, such as natural killer cells, that eliminate virus-infected cells and guide the development of a subsequent adaptive immune response. Consequently, there is great interest in developing molecularly defined immunostimulatory nucleic acids for the therapy of viral infection and cancer 6, 7 .
Nucleic acid-sensing PRRs come in several flavors, including tolllike receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) and nucleotide oligomerization domain (NOD)like receptors (NLRs). The RLR class is localized to the cytoplasm and specialized for RNA-sensing. Its members include RIG-I, melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology-2 (LGP2) receptors [8] [9] [10] .
RIG-I was initially identified as the RLR responsible for activation of the IFN-β promoter in response to sensing viral RNAs 11 from hepatitis C, Sendai, vesicular stomatitis, rabies, influenza and encephalitis viruses. RIG-I responds to RNAs containing a 5′-triphosphate by type I IFN production, apoptosis induction and inflammasome activation 12, 13 . The RIG-I protein contains two N-terminal caspase recruitment domains (CARDs), a central DExH box helicase/ATPase and a C-terminal regulatory domain (CTD). A comparative sequence alignment of the CTDs of RIG-I, MDA5 and LGP2 is shown in Figure 1a . It has been proposed that the CARD domains of RIG-I are autoinhibited by other domains of the protein, with RNA-ligand binding inducing a conformational change, resulting in RIG-I dimerization 9, 10 .
There is a considerable body of literature on RNA targets of RIG-I, with binding preference claims ranging from ssRNA to dsRNA, with and without phosphate-end modifications and overhang residues. Two initial studies independently established that RIG-I specifically targets 5′-triphosphate-containing viral RNAs 14, 15 , thereby distinguishing viral from host transcripts, as the 5′ ends of the latter are A r t i c l e s either capped by 7-meG or removed during the maturation process. More recently, two groups showed that RIG-I required base paired structures in conjunction with attached 5′-triphosphate to trigger antiviral signaling 16, 17 . In addition, it has been shown that, besides viral RNA, RNA helicase RIG-I is also activated by RNA polymerase IIImediated conversion of microbial DNA into 5′-ppp dsRNA 18, 19 .
Single-molecule protein-induced fluorescent enhancement studies have shown that RIG-I is a 5′-ppp RNA-dependent ATP-powered translocase along the entire length of dsRNA 20 . In addition, the 5′-to-3′ directed movement of RIG-I along the duplex axis appears to occur without unwinding the RNA duplex. These studies also showed that the CARD regulatory domains suppressed translocation in the absence of 5′-ppp RNA.
Previous studies determined the crystal structure of the C-terminal domain of RIG-I in the free state and, based on NMR titration studies, identified a basic RNA binding surface within the CTD that appeared to be critical for 5′-ppp RNA recognition 21, 22 . Of note, these studies were performed using 5′-ppp RNA generated by in vitro transcription, which is known to result in RNA molecules that are not well defined and that contain unexpected contamination of ssRNA with duplex RNA. Recently, we used a chemical synthetic approach to generate defined 5′-ppp RNA and found that RIG-I required base paired structures in conjunction with attached 5′-triphosphate to trigger antiviral signaling 17 . These results suggested that the minimal complex should contain the CTD of RIG-I and a blunt-end RNA duplex containing 5′-ppp termini. Here we provide new biophysical and crystallographic studies, complemented by functional studies further characterizing this interaction.
RESULTS

Binding affinity of 5′-ppp dsRNA versus 5′-ppp ssRNA
We used isothermal titration calorimetry (ITC) to measure and compare the binding affinity of RIG-I CTD for 5′-ppp-modified dsRNA and ssRNA. We measured a binding affinity of 29.2 nM for complex formation between RIG-I CTD and self-complementary blunt-end 5′-ppp dsRNA 12-mer in 100 mM NaCl solution ( Fig. 1b ; the complete ITC data are plotted in Supplementary Fig. 1 ). The stoichiometry of binding was approximately two CTDs bound per duplex, reflecting CTD molecules bound to both 5′-ppp ends of the self-complementary RNA duplex. The binding affinity decreased by a factor of 16.7 to 488 nM for complex formation between RIG-I CTD and single-stranded 5′-ppp ssRNA ( Fig. 1c) , consistent with earlier results that established a requirement for a blunt-end 5′-ppp dsRNA for maximal binding affinity 16, 17 .
Binding affinity of 5′-ppp dsRNA versus 5′-OH dsRNA
We used ITC to measure the binding affinity of RIG-I CTD for dsRNA as a function of 5′-triphosphorylation. The binding affinity of RIG-I CTD for self-complementary blunt-end 5′-ppp dsRNA 12-mer was dependent on NaCl concentration, with the binding affinity decreasing by a factor of 7.3 from 29.2 nM in 100 mM NaCl A r t i c l e s solution ( Fig. 1b) to 215 nM in 250 mM NaCl solution (Fig. 1d) .
The 5′-phosphorylation status of the dsRNA is also important, as the binding affinity decreased by a factor of 5.1 from 215 nM for blunt-end 5′-ppp dsRNA 12-mer ( Fig. 1d ) to 1.10 μM for its 5′-OH dsRNA counterpart ( Fig. 1e) , both in 250 mM NaCl solution.
Crystal structure of 5′-ppp dsRNA bound to RIG-I CTD We previously showed that structural characterization of protein-RNA interactions involving either 5′-or 3′-end RNA recognition by protein modules in a duplex context was facilitated by the use of self-complementary duplexes, whereby the protein modules bound to both ends of the duplex. Using this approach, we structurally characterized P element-induced wimpy testis (Piwi)/Argonaute/ Zwille (PAZ) domain recognition of 2-nt overhangs at 3′ ends of dsRNA 23 , Piwi protein recognition of 5′-p ends of dsRNA 24 and La protein recognition of UUU-3′ RNA ends 25 . More recently, the same approach has been adopted by other groups to structurally characterize recognition of 5′-OH ends of dsRNA by the CTDs of LGP2 (ref. 26) and Ebola viral protein VP35 (ref. 27 ). So far, there has been no structural information on protein-RNA complexes of 5′-ppp RNA bound to either RIG-I or MDA5. By contrast, the structure of TLR3 had been solved with bound dsRNA 28 . We initiated crystallization of the RIG-I CTD with self-complementary 5′-ppp dsRNA of 10-mer, 12-mer and 14-mer lengths, with the goal of generating complexes involving RIG-I CTD recognition of 5′-ppp termini of blunt-end dsRNA (details of protein expression and chemical synthesis of 5′-ppp RNA are described in Online Methods). We obtained crystals of RIG-I CTD (positions 792-925, Fig. 1a ) bound to both ends of a chemically synthesized self-complementary 5′-pppGACGCUAGCGUC 12-mer dsRNA and solved the structure to 2.55-Å resolution (details of crystallization and structure determination are described in Online Methods; X-ray statistics are listed in Table 1 ).
The crystal structure of the complex is shown in Figure 2a . The self-complementary 5′-ppp dsRNA 12-mer forms a fully paired duplex (omit electron density map shown in Supplementary Fig. 2) , with RIG-I CTDs ( Fig. 2a , salmon) bound at either end of the duplex ( Fig. 2a , green) in the complex (intermolecular contacts shown schematically in Fig. 2b) . To our surprise, we could only trace two phosphates at the 5′ end of the RNA (Fig. 2c) , indicative of hydrolytic cleavage 29 and loss of the terminal phosphate of bound 5′-ppp dsRNA during generation and/or crystallization of the complex.
Intermolecular contacts in the complex
Intermolecular contacts toward one end of the complex are highlighted in Figure 2c , with the observable 5′-pp end of the bound dsRNA sequestered within a basic lysine-rich patch on the RIG-I CTD in the complex (Fig. 2d) . The side chain of Phe853 stacks over both bases of the terminal base pair of the dsRNA in the complex, thereby readily explaining the requirement for a blunt-end duplex (Fig. 2c) . Specifically, the aromatic ring of Phe853 partially stacks on 5′-G1, whereas the Cα-Cβ bond of Phe853 stacks on C12 ( Supplementary  Fig. 3 ). Individual phosphates of the 5′-ppp end are labeled α, β and γ, with the α phosphate closest to the terminal base. The nonbridging phosphate oxygens of the α phosphate are hydrogen bonded to the side chains of Lys861 and Lys888, whereas the phosphate oxygens of the β phosphate are hydrogen bonded to the side chains of Lys861, A r t i c l e s His847 and Lys858 (Fig. 2c) . In addition, the nonbridging phosphate oxygen between nucleosides 2 and 3 hydrogen-bonds to the side chain of Lys907 in the complex. Complex formation results in a buried surface area of 328 Å 2 at either end of the complex. We modeled the missing γ phosphate within the basic 5′-phosphorylated end-binding pocket in our structure of RIG-I bound to blunt-end 5′-pp dsRNA (Fig. 3a) , so as to generate a complex with bound 5′-ppp dsRNA. In this model of the complex, the γ phosphate oxygens could form potential hydrogen bonds with Lys849 and Lys851, though this should be considered to be speculative at this time.
Conformational change in RIG-I CTD on complex formation
Superposition of the previously reported crystal structure of the free RIG-I CTD 22 (Fig. 3b, blue) with the current structure of the complex with bound blunt-end 5′-pp dsRNA 12-mer ( Fig. 3b, salmon) is shown in stereo in Figure 3b . The CTDs superposed well (r.m.s. deviation = 0.49 Å), except for differences in the loop spanning positions 847-856 ( Fig. 3b, bold colors ) and the orientation of Phe853, whose aromatic ring and Cα-Cβ bond are involved in stacking interactions with the terminal base pair in the complex. It is important to stress that the conformation of the CTD loop in the structure of the present complex with bound 5′-pp dsRNA could differ from that of the yet-undetermined complex with bound 5′-ppp dsRNA.
5′-ppp dsRNA binding pockets of RIG-I, MDA5 and LGP2
A comparison of the sequences of the CTDs (Fig. 1a) shows that RIG-I residue Lys888 is conserved between RIG-I, MDA5 and LGP2 and that RIG-I residue Lys851 is conserved between RIG-I and MDA5, whereas there is no conservation between RIG-I residues His847, Lys849, Lys858 and Lys861 and their counterparts in MDA5 and LGP2 (Fig. 1a) . As a result, the highly basic nature of the 5′-ppp binding pocket within the CTD of RIG-I ( Fig. 3c , dashed red/circled region) becomes less basic in the corresponding surface segment of MDA5 ( Fig. 3d) and becomes hydrophobic for LGP2 ( Fig. 3e) . In addition, although cavities exist on this surface segment for RIG-I ( Fig. 3c) and, to some extent, LGP2 (Fig. 3e) , there is an outwards protrusion for MDA5 (Fig. 3d) . These results suggest that the complex of RIG-I CTD bound to a blunt-end 5′-phosphorylated RNA duplex reported here should be distinct from corresponding complexes with MDA5 and LGP2. There are adjacent basic patches in the CTD domains of MDA5 and LGP2 ( Fig. 3d,e , lower left corner) that could provide alternate recognition sites for 5′-ppp RNAs in these complexes, but the involvement of these sites in the recognition of MDA5 or LGP2 CTDs is unclear at present.
In vitro analysis of RIG-I CTD mutants on binding affinity
To assess the importance of residues lining the basic 5′-ppp recognition patch, we recombinantly expressed single, double and triple RIG-I CTD mutants. We monitored the binding of blunt-end 5′-ppp dsRNA to wild-type and mutant RIG-I CTDs by ITC. The 5′-ppp dsRNA bound to wild-type RIG-I CTD in 100 mM NaCl, 2 mM MgCl 2 , buffer with a binding affinity of 29.2 nM, with approximately two CTD domains bound per duplex (Fig. 4a) . This affinity dropped to 162 nM for the single H847A CTD mutant (Fig. 4b) , to 649 nM for the double H847A K858A mutant ( Fig. 4c) and to >15 μM for the triple H847A K858A K851A mutant (Fig. 4d) .
We also assessed RIG-I CTD 5′-ppp dsRNA binding by electrophoretic mobility shift analysis. We labeled a triphosphorylated 11-mer at the 3′ end using RNA ligase and radioactive pCp, yielding the 12-mer palindromic sequence used in crystallographic or calorimetric studies, although with an additional 3′-phosphate. Consistent with the binding constants determined by calorimetry, 100 nM protein completely shifted the 20-nM input 5′-ppp dsRNA, and the H847A mutation reduced binding by a factor of ~10 (Fig. 4e) . Double or triple mutations weakened the interaction to a point where the complex was no longer stable under electrophoresis conditions, even in the presence of 10 μM protein.
In vivo analysis of RIG-I mutants lining the binding pocket
To confirm the biological significance of the observed intermolecular contacts involving the 5′-phosphorylated end of the RNA in the crystal structure of the 5′-pp dsRNA bound to RIG-I CTD, we mutated all lysines, histidines and phenylalanines that line the observed binding pocket to alanine in full-length RIG-I (see Supplementary Table 1 for a complete list of RIG-I mutants). We overexpressed wild-type and mutant full-length human RIG-I in human HEK 293 cells. We stimulated the cells with synthetic 5′-ppp ssRNA, 5′-ppp dsRNA or 5′-OH dsRNA. We analyzed RIG-I activation in cells based on the formation of the interferon-inducible and Lys888 (α-phosphate contact) strongly or completely abrogated activation of RIG-I by 5′-ppp dsRNA ( Fig. 5a ; mutated positions shown in Fig. 5b) . By contrast, the His847 (β-phosphate contact) had little impact on the RIG-I activity in cells. In the same setting, the 5′-OH dsRNA was inactive. Mutation of Phe853, which is important for terminal base pair stacking, reduced activation, whereas mutation of Lys907, which hydrogen-bonds to the internucleotide phosphate between nucleosides 2 and 3, completely abolished 5′-ppp dsRNA-induced IP-10 ( Fig. 5a ; mutated positions shown in Fig. 5b) . Although the K849A and K851A single mutants showed little impact on activity, we confirmed their functional contribution by dose-response analysis of the K849A K851A double mutant ( Fig. 5a and Supplementary Fig. 4) .
In vivo analysis of RNA 2′-OCH 3 substituent effects
In efforts to evaluate the in vivo relevance of the binding orientation observed in the crystal structure of RIG-I CTD bound to 5′-pp RNA duplex, we synthesized a series of 5′-ppp RNA analogs containing 2′-OCH 3 residues at positions 1-6 within a blunt-end 5′-ppp dsRNA 24-mer context and analyzed the interferonstimulating activity of these duplexes in human peripheral blood mononuclear cells (PBMCs). To avoid the recognition of short RNA by immune receptors other than RIG-I, such as TLR7 and TLR8, we stimulated PBMCs in the presence of chloroquine. In this setting, immune recognition of short dsRNA in monocytes is exclusively mediated by RIG-I. The sequences of the first six nucleotides of the test 5′-ppp dsRNA 24-mer and of the self-complementary 5′-ppp dsRNA 12-mer used for crystallization were identical. We found that 2′-OCH 3 incorporation at nucleosides 1 and 2 results in complete and 30% loss of in vivo activity, respectively, whereas 2′-OCH 3 incorporation at nucleosides 3-6 had no impact on the in vivo activity (Fig. 6a) . The orientations of the 2′-OH groups of nucleosides 1, 2 and 3 are highlighted in the structure of the complex (Fig. 6b, red) .
DISCUSSION
Unique features of  and  5′-pp recognition
The RIG-I CTD targets both ends of the self-complementary 5′-pp dsRNA 12-mer in the crystal structure of the complex. The α and β 5′-phosphates are anchored in a basic pocket through electrostatic and multiple hydrogen bonding interactions (Fig. 2c) , with sufficient room in the basic pocket to model in the γ 5′-phosphate (Fig. 3a) . The side chains of Lys861 and Lys888 hydrogen-bond to the α 5′-phosphate and the side chains of His847 and Lys858 hydrogen bond to the β 5′-phosphate ( Fig. 2c) , whereas the side chains of additional lysines, including Lys849 and Lys851, could provide potential electrostatic and hydrogen binding sites for interaction with the γ 5′-phosphate ( Fig. 3a) . Functional data support the involvement of Lys849 and Lys851 for lower concentrations of RNA (Supplementary Fig. 4) .
The RIG-I CTD recognizes blunt-end duplexes as a consequence of the aromatic ring and Cα-Cβ bond of Phe853 stacking on the terminal base pair (Fig. 2c) . More specifically, the observed partial stacking of the Phe853 on the 5′-base G1 (Supplementary Fig. 3 ) could provide an explanation for better recognition of the 5′-purine bases Figure 4 ITC and electrophoretic mobility shift studies of the binding of blunt-end 5′-ppp dsRNA 12-mer to wild-type and mutants of RIG-I CTD. ITC binding curves for blunt-end 5′-ppp dsRNA 12-mer binding to wild-type (a), H847A single mutant (b), H847A K858A double mutant (c) and H847A K858A K851A triple mutant (d) RIG-I CTD in 100 mM NaCl and 2 mM MgCl 2 buffer. (e) Palindromic radiolabeled 5′-ppp dsRNA 12-mer was incubated at increasing concentrations of recombinant protein under the same salt and buffer conditions as those of the ITC experiment. The complexes were resolved on a native polyacrylamide gel. Increasing numbers of mutation in the triphosphate-binding pocket of the protein weaken RNA binding and reduce the distinct gel shift seen for the wild-type protein to a smear. To ensure that the palindromic 5′-ppp RNA was exclusively present as dsRNA rather than a hairpin, we preannealed the RNA at 5 μM strand concentration and only diluted it to 20 nM before the incubation with protein.
A r t i c l e s with which viruses initiate their RNA replication. Further, the loop that contains Phe853 undergoes a conformational transition upon complex formation that facilitates this stacking interaction (Fig. 3b) . In addition, the alignment of nucleoside 1 at the 5′-ppp end is facilitated by a hydrogen bond between the purine N7 position and the side chain of Lys858 (Fig. 2c) .
The RIG-I CTD also contacts the sugarphosphate backbone spanning nucleosides 1-3 counting from the 5′-ppp end of the dsRNA duplex in the complex. Specifically, the sugar 2′-OH of nucleoside 1 is hydrogen bonded to the side chain of His830, perhaps contributing to the preference of RIG-I for RNA over DNA, whereas the phosphate linking nucleosides 2 and 3 is hydrogen bonded to side chain of Lys907 (Fig. 6b) . In addition, Lys849 forms hydrogen bonds with the backbone phosphate between residues 8, 9 and 10 ( Fig. 2b) , though this could reflect crystal-packing interactions. Finally, only one CTD targets the 5′-ppp blunt end of the RNA duplex, and we can eliminate models of the complex in which the CTD dimerizes on the same end of the RNA.
These results unambiguously define the elements associated with recognition of the 5′-pp end of the dsRNA by the CTD of RIG-I and, by extension, the intact protein. This conclusion is validated by our supporting data discussed below, which analyzes the impact of binding pocket mutations and 2′-OCH 3 RNA modifications on the interferon response in the context of full-length RIG-I.
Correlation of structure with binding pocket mutation data
The results of binding pocket mutations identify key positions (Lys861, Lys888 and Lys907) that are all absolutely required for in vivo functional activation of RIG-I upon binding 5′-ppp dsRNA (Fig. 5a) . According to the crystal structure, Lys861 is involved in hydrogen bonds to both the α and β phosphates at the 5′ end of the bound RNA (Fig. 5b) . Lys888 contributes two hydrogen bonds to the α 5′-phosphate, whereas Lys907 contributes a hydrogen bond to the bridging phosphate between nucleosides 2 and 3 of the 5′ end of the bound dsRNA ( Fig. 6b) . Furthermore, considerable contribution to functional RIG-I activity comes from Lys858 (Fig. 5a) , which binds to the β 5′-phosphate and to the N7 of the guanosine base of nucleoside 1 of the 5′ end of dsRNA ( Fig. 5b) , as well as from Phe853 (Fig. 5a) , which stacks on the first base pair of the blunt end in the structure of the complex ( Fig. 5b and Supplementary Fig. 3 ).
Lys849 and Lys851, which form part of the basic patch and are potential candidates for interaction with the γ 5′-phosphate ( Fig. 3a) , are not required but contribute to functional activation at low concentrations of RNA (Supplementary Fig. 4) . Furthermore, His847, which forms one hydrogen bond to the β 5′-phosphate ( Fig. 5b) , makes a functional contribution, as confirmed by results obtained from the double mutant of H847A K858A (Fig. 5a) .
Further support for a functional role of His847 comes from the binding studies using recombinant CTD of RIG-I with a H847A mutation (Fig. 4b) .
ITC-based in vitro binding studies establish a decrease in binding affinity by a factor of 5.6 for the H847A mutant (Fig. 4b) and a further decrease in binding affinity of a factor of 4.0 for the H847A K858 double mutant (Fig. 4c) . Both His847 and Lys858 are coordinated to the β phosphate in the crystal structure of RIG-I CTD bound to 5′-pp dsRNA (Fig. 2c) .
Together, a comparison of structural data with in vivo functional and in vitro binding data reveals that binding to the α and β 5′-phosphates, the first guanosine base, the bridging phosphate between the second and the third nucleoside and the first base pair of the blunt end are the primary sites that determine the interaction between RIG-I and 5′-ppp dsRNA. Our in vivo functional data currently shed no light on the potential role of Lys849 and Lys851 in targeting the γ phosphate. The in vivo functional contribution of His847, which forms a hydrogen bond to the β 5′-phosphate in the crystal structure of the complex (Fig. 5b) , and its potential candidate role in targeting the γ 5′-phosphate require further investigation. Further clarification on this point will require detection of the γ 5′-phosphate and its intermolecular contacts in the structure of RIG-I CTD bound to 5′-ppp dsRNA.
Correlation of structure with 2′-OCH 3 modification data
The complete loss of activity observed with the 5′-ppp RNA 24-mer duplex containing 2′-OCH 3 at position 1 (Fig. 6a) most likely reflects the expected steric conflict between the trans-C3′-oriented 2′-OCH 3 group and the side chain of His830 (Fig. 6b) . This nucleoside is additionally fixed through Watson-Crick base pairing with the 3′-terminal nucleoside from the opposite strand and through a stacking interaction with the aromatic side chain of Phe853 as well as through multiple hydrogen bonding interactions involving its α and β 5′-phosphates ( Fig. 5b) , thereby precluding the formation of productive alternative configurations.
The observed 30% loss in activity following the incorporation of the 2′-OCH 3 group at nucleoside 2 (Fig. 6a ) most likely reflects this position's proximity to side chain of Cys829 (Fig. 6b) . Moreover, the internucleotide bond between the second and third nucleosides of the bound 5′-pp RNA duplex is also involved in a critical helix-orienting interaction with the side chain of Lys907 (Figs. 6b) .
The 2′-OH groups of residues 3-6 on the 5′-ppp strand of the RNA duplex are solvent oriented and make no minor-groove contacts with protein side chains in the crystal structure of the complex. This explains the experimental observation that nucleosides at positions 3-6 can tolerate 2′-OCH 3 substitutions without a loss of activity (Fig. 6a) . A r t i c l e s These 2′-OCH 3 modification data provide evidence that the same binding orientation and intermolecular contacts are adopted for blunt-end 5′-ppp RNA duplex recognition in its complex with bound RIG-I CTD in the crystal (bound as 5′-pp RNA duplex) compared to its complex with full-length RIG-I under in vivo conditions in solution.
Future studies
In the future, we plan to attempt crystallization and structure determination of complexes of longer 5′-ppp RNA and RIG-I constructs that include the helicase domain, so as to define the fold of the helicase domain as well as to identify the nature of the intramolecular (associated with the potential dimerization of RIG-I) and intermolecular (associated with potential helicase-RNA recognition) contacts in the bound state. These will be supplemented with in vivo functional assays to analyze the impact of potential intermolecular contacts associated with the helicase domain on the interferon response.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Accession codes. Protein Data Bank: The atomic coordinates and structure factors for the RIG-I CTD bound to blunt-end 12-mer ppRNA have been deposited under accession code 3NCU.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
